Bosutinib As Therapy for Chronic Phase Chronic Myeloid Leukemia Following Failure with Imatinib Plus Dasatinib and/or Nilotinib: 24-Month Minimum Follow-up Update
| Autor: | Khoury, H. Jean 1, Gambacorti-Passerini, Carlo 2, Kantarjian, Hagop M. 3, Kim, Dong-Wook 4, Marin, David 5, Dorlhiac-Llacer, Pedro E *, 6, Zaritskey, Andrey *, 7, Navarro, Juan *, 8, Bullorsky, Eduardo O *, 9, Assouline, Sarit 10, Leip, Eric *, 11, Kelly, Virginia 11, Turnbull, Kathleen *, 11, Besson, Nadine *, 12, Cortes, Jorge E 13 |
|---|---|
| Zdroj: | In Blood 16 November 2012 120(21):3785-3785 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|